Schedule 13G ownership disclosure

ACHILLES THERAPEUTICS PLC

American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share · CUSIP: 00449L102

Event date: 2024-12-31

Filing-level shares
4,100,002
Percent of class
9.97%
  • BML Investment Partners, L.P.

    Shares: 4,100,002 · Class: 9.97%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001373604-25-000024
Form type
SCHEDULE 13G/A
Filer
Achilles Therapeutics plc
CIK
CIK 1830749
Filed
Feb 13, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub